Acipimox

Pharmaceutical Ingredients (for Research and Experimental Use)

Antilipemic Ingredients (for Research and Experimental Use)

Japan

Acipimox: A Long-Acting Antilipemic Agent Acipimox, a nicotic acid [N0082] analogue, is a long-acting antilipemic agent. It inhibits the release of non-esterified fatty acids from adipose tissue and reduces total serum triglyceride and cholesterol levels. These decrease occur in the in the very low density lipoprotein (VLDL) fraction and in the low density lipoprotein (LDL) fraction. In addition, acipimox increases high density lipoprotein (HDL) cholesterol. It is also reported to improve insulin sensitivity in diabetes. It is reported that acipimox acts on the nicotinic acid receptor, inhibiting the enzyme triglyceride lipase. (The product is for research purpose only.)

MFCD00865757

135726995.0

777471.0

GHS07

Warning

H319 : Causes serious eye irritation.

P264 : Wash skin thoroughly after handling. P280 : Wear eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

UQ2453000

111.0

For laboratory research and development purposes only.

>98.0%(GC)

Solid

154.13

Fukaya factory is certified for GMP, ISO14001:2004 (JQA-EM5386) and IQ Net (JP-JQA-EM5386).

White to Almost white powder to crystal

C6H6N2O3

2933.99.8290

>98.0%(GC)